Insufficient scRNA-seq data for expression of SLC25A51 at single-cell level.
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 26% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 411.58 | 1444 / 1445 | 100% | 8.75 | 183 / 183 |
brain | 100% | 386.23 | 2640 / 2642 | 100% | 8.16 | 705 / 705 |
intestine | 100% | 403.59 | 966 / 966 | 100% | 6.99 | 526 / 527 |
breast | 100% | 528.00 | 459 / 459 | 100% | 11.17 | 1115 / 1118 |
stomach | 100% | 310.70 | 359 / 359 | 100% | 7.83 | 285 / 286 |
lung | 100% | 497.06 | 577 / 578 | 100% | 8.20 | 1152 / 1155 |
ovary | 100% | 356.09 | 180 / 180 | 99% | 7.00 | 427 / 430 |
thymus | 100% | 409.87 | 653 / 653 | 99% | 6.34 | 598 / 605 |
prostate | 100% | 376.71 | 244 / 245 | 99% | 7.29 | 498 / 502 |
uterus | 100% | 352.39 | 170 / 170 | 99% | 7.70 | 453 / 459 |
skin | 100% | 487.93 | 1809 / 1809 | 99% | 8.11 | 465 / 472 |
kidney | 100% | 559.27 | 89 / 89 | 98% | 6.40 | 887 / 901 |
pancreas | 100% | 340.33 | 328 / 328 | 98% | 6.02 | 175 / 178 |
bladder | 100% | 331.95 | 21 / 21 | 97% | 6.79 | 487 / 504 |
adrenal gland | 100% | 382.45 | 258 / 258 | 92% | 5.38 | 212 / 230 |
liver | 99% | 227.39 | 223 / 226 | 83% | 3.95 | 339 / 406 |
adipose | 100% | 628.55 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 7.14 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 8.15 | 29 / 29 |
muscle | 100% | 417.92 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 425.12 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 6.73 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.58 | 1 / 1 |
blood vessel | 100% | 331.00 | 1333 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 451.03 | 918 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 412.74 | 834 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0019646 | Biological process | aerobic electron transport chain |
GO_1990549 | Biological process | mitochondrial NAD transmembrane transport |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0051724 | Molecular function | NAD transmembrane transporter activity |
Gene name | SLC25A51 |
Protein name | Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51 (Mitochondrial NAD(+) transporter SLC25A51) (Mitochondrial carrier triple repeat protein 1) (Solute carrier family 25 member 51) |
Synonyms | MCART1 |
Description | FUNCTION: Mitochondrial membrane carrier protein that mediates the import of NAD(+) into mitochondria . Mitochondrial NAD(+) is required for glycolysis and mitochondrial respiration . Compared to SLC25A52, SLC25A51-mediated transport is essential for the import of NAD(+) in mitochondria . The transport mechanism, uniport or antiport, its electrogenicity and substrate selectivity, remain to be elucidated. . |
Accessions | ENST00000242275.7 ENST00000377716.6 Q9H1U9 |